OSR Holdings Secures $80 Million for Accelerating Glioblastoma Therapies through Strategic Partnership OSR Holdings, Inc. announces an $80 million stock purchase agreement with White Lion GBM Innovation Fund to enhance glioblastoma treatments, driving healthcare innovation.

OSR Holdings Secures $80 Million for Accelerating Glioblastoma Therapies through Strategic Partnership #None #Glioblastoma #OSR_Holdings #White_Lion_Fund